OPENING OF BANKRUPTCY

EXTENSE PHARMA

Export PDF

Financial year 2021 · closed on 31/12/2021

Net result

-120,8 k €

-94.8% YoY

Gross margin

-43 k €

-318.6% YoY

Equity

-437 k €

-38.2% YoY

Company — Opening of bankruptcy.

What does EXTENSE PHARMA do?

EXTENSE PHARMA is a Private company with limited liability incorporated in 2009. Its main activity is: Agents specialised in the sale of other particular products. Its registered office is in Wavre.

Legal situation

● Opening of bankruptcy

BCE/KBO no. / VAT

BE 0821.673.538

Incorporation

17/12/2009

Legal form

Private company with limited liability

Registered office

Rue Charles Jaumotte 29-31
1300 Wavre · WallonieSee on map

Contributed capital

168 600,00 €

Latest accounts

31/12/2021

Activities (NACE)

46180Agents specialised in the sale of other particular products· main 46180Agents specialised in the sale of other particular products 10860Manufacture of homogenised food preparations and dietetic food 10860Manufacture of homogenised food preparations and dietetic food

Joint committees (1)

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 12 financial years

	2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010
Income statement
Gross margin	-43 k €	-319%	19,7 k €	+107%	-280,6 k €	-218%	-88,3 k €	-186%	102,8 k €	+36.4%	75,3 k €	+1.4%	74,3 k €	+78.9%	41,5 k €	-19.3%	51,5 k €	-49.7%	102,3 k €	+91.8%	53,3 k €	+6.1%	50,3 k €
EBITDA	-43 k €	-338%	18,1 k €	+106%	-282,8 k €	-207%	-92,1 k €	-199%	93,1 k €	+31.3%	70,9 k €	-3.4%	73,5 k €	+91.8%	38,3 k €	-23.6%	50,1 k €	-25.8%	67,6 k €	+46.7%	46,1 k €	-1.5%	46,8 k €
Operating result	-100,5 k €	-149%	-40,3 k €	+88.5%	-350,9 k €	-156%	-136,8 k €	-275%	78,3 k €	+114%	36,6 k €	-0.1%	36,6 k €	+139%	15,3 k €	-43.8%	27,2 k €	+45.3%	18,7 k €	+18.8%	15,8 k €	-22.7%	20,4 k €
Net result	-120,8 k €	-94.8%	-62 k €	+83.7%	-379,7 k €	-148%	-153,1 k €	-526%	35,9 k €	+205%	11,8 k €	-21.6%	15 k €	+243%	4,4 k €	-68.0%	13,7 k €	+41.0%	9,7 k €	-10.8%	10,9 k €	+26.7%	8,6 k €
Balance sheet
Equity	-437 k €	-38.2%	-316,3 k €	-24.4%	-254,3 k €	-303%	125,4 k €	-55.0%	278,5 k €	+201%	92,6 k €	-29.2%	130,9 k €	+13.0%	115,9 k €	+88.5%	61,5 k €	+28.7%	47,8 k €	+25.5%	38,1 k €	+40.0%	27,2 k €
Total assets	394,2 k €	-13.6%	456 k €	-46.1%	846,2 k €	-40.6%	1,4 M €	+42.6%	998,6 k €	+21.4%	822,5 k €	+35.5%	607 k €	+57.3%	385,9 k €	+118%	177,3 k €	+55.0%	114,4 k €	-32.2%	168,8 k €	+21.2%	139,3 k €
Cash	82,7 €	-86.3%	602,7 €	+638%	81,7 €	-99.9%	56,9 k €	-13.3%	65,6 k €	-28.3%	91,5 k €	+214%	29,2 k €	-59.6%	72,2 k €	+1680%	4,1 k €	-64.2%	11,3 k €	-29.0%	16 k €	-63.6%	43,9 k €
Debts	831,2 k €	+7.6%	772,3 k €	-29.8%	1,1 M €	-15.3%	1,3 M €	+80.4%	720,1 k €	-1.3%	729,9 k €	+53.3%	476,1 k €	+76.4%	270 k €	+133%	115,9 k €	+74.0%	66,6 k €	-49.1%	130,7 k €	+51.4%	86,3 k €
Other
Workforce	–		–		–		–		–		–		–		–		–		1,0 ETP	0.0%	1,0 ETP		–

Governance

Board of directors

Seen on filing of 31/12/2021 · 1 active

Active mandates

Christel WULLAERT

Manager · since 17 décembre 2009

Active

At this address

Other companies at this address

Company	CBE no.
BALCAEN CONSTRUCTION ENTREPRISE● Bankrupt	0418.913.603
CIS CONSTRUCT● Bankrupt	0896.823.891
EQUINOXIAL● Active	0642.823.849
EXPOPOLIS● Active	0810.435.889
FConsult● Active	0676.364.964
GROUPE THIBAULT GROEP● Active	0464.154.007
HUZ CONSTRUCTION● Active	0875.644.041
LELLA L● Active	0887.577.912
L' OFFICE DU PRET HYPOTHECAIRE● Bankrupt	0417.744.752
M.F.N.C.● Bankrupt	0716.885.725
MN GROUP● Active	1020.489.488
Nostra Group● Bankrupt	0802.548.207
ODPH HAINAUT● Bankrupt	0633.550.748
OFFICE DU PRET HYPOTHECAIRE DE Belgique● Bankrupt	0427.563.627
PAMPAM FAST FOOD● Bankrupt	0681.392.930
PHI TRADING● Bankrupt	0826.256.094
PHIZIMMO● Active	0836.059.331
RENOVE CONSEILS ET TOITURE● Active	0654.761.975
RS HABITAT● Bankrupt	0537.667.040
SAINT-OGER● Liquidation	0518.929.214

Annual accounts

Full financial information

	2021	2020	2019	2018	2017	2016
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Abridged model
Start of the financial year	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017	01/01/2016
Closing of the financial year	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017	31/12/2016
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	24/10/2022	24/10/2022	21/10/2021	25/07/2019	28/08/2018	23/08/2017
General meeting	17/10/2022	17/10/2022	29/05/2020	15/05/2019	25/05/2018	26/05/2017
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

12 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2021	17/10/2022	24/10/2022	French	PDF
Micro model	31/12/2020	17/10/2022	24/10/2022	French	PDF
Micro model	31/12/2019	29/05/2020	21/10/2021	French	PDF
Micro model	31/12/2018	15/05/2019	25/07/2019	French	PDF
Micro model	31/12/2017	25/05/2018	28/08/2018	French	PDF
Abridged model	31/12/2016	26/05/2017	23/08/2017	French	PDF
Abridged model	31/12/2015	27/05/2016	07/07/2016	French	PDF
Abridged model	31/12/2014	29/05/2015	31/08/2015	French	PDF
Abridged model	31/12/2013	30/05/2014	04/07/2014	French	PDF
Abridged model	31/12/2012	26/05/2013	04/07/2013	French	PDF
Abridged model	31/12/2011	25/05/2012	19/11/2012	French	PDF
Abridged model	31/12/2010	30/06/2011	15/07/2011	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2021 · 1 active

Active mandates

Christel WULLAERT

Manager · since 17 décembre 2009

Active

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office06/12/2022
SIEGE SOCIAL
PDF
Registered office21/04/2022
SIEGE SOCIAL
PDF
Capital / shares13/03/2017
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Registered office24/02/2017
SIEGE SOCIAL
PDF
Registered office31/10/2011
SIEGE SOCIAL
PDF
Capital / shares13/07/2011
CAPITAL, ACTIONS
PDF
Other07/01/2010
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2021
Annual accounts 2021-120,8 k €↓
2020
Annual accounts 2020-62 k €↑
2019
Annual accounts 2019-379,7 k €↓
2018
Annual accounts 2018-153,1 k €↓
2017
Annual accounts 201735,9 k €↑
2016
Annual accounts 201611,8 k €↓
2015
Annual accounts 201515 k €↑
2014
Annual accounts 20144,4 k €↓
2013
Annual accounts 201313,7 k €↑
2012
Annual accounts 20129,7 k €↓
2011
Annual accounts 201110,9 k €↑
2010
Annual accounts 20108,6 k €
17/12/2009
IncorporationPrivate company with limited liability

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

EXTENSE PHARMA

Overview

What does EXTENSE PHARMA do?

Trend over 12 financial years

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline